Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction

Objectives: Left ventricular (LV) dysfunction heart failure is one of the causes of morbidity and mortality following ST elevation myocardial infarction (STEMI). This study was done to determine the clopidogrel effect in preventing reduced LV function in pa-tients with STEMI. Methods: In this study,...

Full description

Bibliographic Details
Main Authors: Pejman Khosravi, Hasan Shemirani, Behnoud Hedayatpour, Allahyar Golabchi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2010-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2010;volume=1;issue=4;spage=257;epage=259;aulast=Khosravi
_version_ 1819265919051890688
author Pejman Khosravi
Hasan Shemirani
Behnoud Hedayatpour
Allahyar Golabchi
author_facet Pejman Khosravi
Hasan Shemirani
Behnoud Hedayatpour
Allahyar Golabchi
author_sort Pejman Khosravi
collection DOAJ
description Objectives: Left ventricular (LV) dysfunction heart failure is one of the causes of morbidity and mortality following ST elevation myocardial infarction (STEMI). This study was done to determine the clopidogrel effect in preventing reduced LV function in pa-tients with STEMI. Methods: In this study, 144 patients with STEMI admitted to the Isfahan University of Medical Sciences hospitals were followed in two groups for one month. The case group received Clopidogrel, 300 mg, on admission and then, 75 mg daily, while the control group received routine therapy for STEMI without Clopidogrel. Left ventricular ejection fraction (LVEF) on the 4 th day and one month after STEMI was measured by echocardiography. The re-sults of LVEF were compared within and between groups. Results: The mean LVEF in the case group on the 4 th day and one month after STEMI were 45.92 and 52.15%, respectively (P<0.001). The mean LVEF in the control group on 4 th day and one month after STEMI were 44.72 and 42.71%, respectively. Conclusions: We suggest that Clopidogrel is effective in preven-tion of LVEF reduction in patients with STEMI.
first_indexed 2024-12-23T20:53:01Z
format Article
id doaj.art-86b82450638848b5b0b42d14d6d37246
institution Directory Open Access Journal
issn 2008-7802
2008-8213
language English
last_indexed 2024-12-23T20:53:01Z
publishDate 2010-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Preventive Medicine
spelling doaj.art-86b82450638848b5b0b42d14d6d372462022-12-21T17:31:36ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132010-01-0114257259Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarctionPejman KhosraviHasan ShemiraniBehnoud HedayatpourAllahyar GolabchiObjectives: Left ventricular (LV) dysfunction heart failure is one of the causes of morbidity and mortality following ST elevation myocardial infarction (STEMI). This study was done to determine the clopidogrel effect in preventing reduced LV function in pa-tients with STEMI. Methods: In this study, 144 patients with STEMI admitted to the Isfahan University of Medical Sciences hospitals were followed in two groups for one month. The case group received Clopidogrel, 300 mg, on admission and then, 75 mg daily, while the control group received routine therapy for STEMI without Clopidogrel. Left ventricular ejection fraction (LVEF) on the 4 th day and one month after STEMI was measured by echocardiography. The re-sults of LVEF were compared within and between groups. Results: The mean LVEF in the case group on the 4 th day and one month after STEMI were 45.92 and 52.15%, respectively (P<0.001). The mean LVEF in the control group on 4 th day and one month after STEMI were 44.72 and 42.71%, respectively. Conclusions: We suggest that Clopidogrel is effective in preven-tion of LVEF reduction in patients with STEMI.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2010;volume=1;issue=4;spage=257;epage=259;aulast=KhosraviHeart failure; Myocardial infarction; Prevention
spellingShingle Pejman Khosravi
Hasan Shemirani
Behnoud Hedayatpour
Allahyar Golabchi
Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
International Journal of Preventive Medicine
Heart failure; Myocardial infarction; Prevention
title Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
title_full Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
title_fullStr Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
title_full_unstemmed Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
title_short Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
title_sort assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
topic Heart failure; Myocardial infarction; Prevention
url http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2010;volume=1;issue=4;spage=257;epage=259;aulast=Khosravi
work_keys_str_mv AT pejmankhosravi assessmentofclopidogrelontheleftventricularejectionfractioninacutemyocardialinfarction
AT hasanshemirani assessmentofclopidogrelontheleftventricularejectionfractioninacutemyocardialinfarction
AT behnoudhedayatpour assessmentofclopidogrelontheleftventricularejectionfractioninacutemyocardialinfarction
AT allahyargolabchi assessmentofclopidogrelontheleftventricularejectionfractioninacutemyocardialinfarction